When BiP protein was stratified according to the lowest and highest quartile using the CPTAC dataset, a remarkable increase in the number of ER- and PR-positive tumors was significantly represented in the tumors with lowest BiP levels, which was also in agreement with mRNA expression showing significantly lower BiP in luminal A breast cancer vs. the other molecular subtypes. This evidence concerns the gene ESR1 and breast cancer.